Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
NSRX
Stock Latest News
The Fly
Nasus Pharma price target lowered to $18 from $19 at Citizens
11d ago
NSRX
Premium
Company Announcements
Nasus Pharma Moves Intranasal Epinephrine Toward Pivotal Trial After Positive Phase 2 Results
11d ago
6K
NSRX
Premium
The Fly
Nasus Pharma advances NS002 to pivotal study following Phase 2 results
12d ago
NSRX
Premium
TipRanks Newswire
Nasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)
18d ago
SER
NSRX
Premium
TipRanks Newswire
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
21d ago
CTMX
NSRX
Premium
Company Announcements
Nasus Pharma’s NS002 Outperforms EpiPen in Phase 2 Anaphylaxis Study, Pivotal Trial Planned for Late 2026
21d ago
6K
NSRX
Premium
The Fly
Nasus Pharma announces topline data from Phase 2 clinical study of NS002
21d ago
NSRX
Premium
Company Announcements
Nasus Pharma Shareholders Approve Capital Increase and Amended Articles at March 5 Meeting
1M ago
6K
NSRX
Premium
Company Announcements
Nasus Pharma Moves March 5 Shareholder Meeting to Virtual-Only Format Amid Israel Security Situation
1M ago
6K
NSRX
Premium
The Fly
Nasus Pharma files to sell 5.39M ordinary shares for holders
1M ago
NSRX
Premium
TipRanks Newswire
Nasus Approaches Key Data Readout That Could Reshape the Multi Billion Dollar Epinephrine Market (NYSE: NSRX)
1M ago
NSRX
XERS
Premium
Company Announcements
Nasus Pharma Files Updated Corporate Presentation With SEC
1M ago
6K
NSRX
Premium
The Fly
Nasus Pharma Ltd trading resumes
1M ago
NSRX
Premium
The Fly
Nasus Pharma Ltd trading halted, volatility trading pause
1M ago
NSRX
Premium
TipRanks Newswire
Nasus Pharma Is Targeting a Validated Market With a Potentially Superior Intranasal Delivery Approach
2M ago
NSRX
Premium
The Fly
Nasus Pharma Ltd trading resumes
2M ago
NSRX
Premium
The Fly
Nasus Pharma Ltd trading halted, volatility trading pause
2M ago
NSRX
Premium
Company Announcements
Nasus Pharma Raises $15 Million in Premium-Priced Private Placement to Fund NS002 Pivotal Program
2M ago
6K
NSRX
Premium
Company Announcements
Nasus Pharma Prices $15 Million Premium Private Placement to Fund NS002 Pivotal Push
2M ago
6K
NSRX
Premium
The Fly
Nasus Pharma Ltd trading resumes
2M ago
NSRX
Premium
The Fly
Nasus Pharma Ltd trading halted, volatility trading pause
2M ago
NSRX
Premium
Company Announcements
Nasus Pharma Calls March 5 Special Meeting to Boost Share Capital and Approve New Equity Incentives
2M ago
6K
NSRX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
